Clinical Trial Update: Comparing the Efficacy and Safety of Chemotherapy Combined With or Without Immunotherapy as Postoperative Adjuvant Regimens in Patients With Resectable Gastric Cancer/Adenocarcinoma of the Esophagogastric Junction After Radical Surgery [Phase 4]

View source ↗

Summary

A Phase 4 trial update describing a study that compares postoperative adjuvant regimens of chemotherapy with or without immunotherapy in patients with resectabl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Adenocarcinoma

Snippet

Sponsor: Liaoning Cancer Hospital & Institute | Conditions: Gastric / Gastroesophageal Junction Adenocarcinoma | Phase 4 | Status: NOT_YET_RECRUITING